GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Genuine Parts Company (GPC) [hlAlert]

Genuine Parts Company Biotech AG is a publicly traded biopharmaceutical company focused on discovering, developing and commercializing new anticancer drugs. GPC Biotech's lead product candidate satraplatin is an oral platinum-based compound that has shown highly statistically significant results for progression-free survival in
a Phase three registrational trial as a second-line chemotherapy treatment in hormone-refractory prostate cancer. The U.S. FDA has granted fast track designation to satraplatin for this indication, and the rolling NDA submission process for this compound has been completed. Satraplatin was in-licensed from Spectrum Pharmaceuticals, Inc. GPC Biotech is also developing a monoclonal antibody with a novel mechanism-of-action against a variety of lymphoid tumors, currently in Phase 1 clinical development, and has ongoing drug development and discovery programs that leverage its expertise in kinase inhibitors.
( Total: 17 Current Stock Recommendations )
Genuine Parts Company   (17)
Sell 18% Hold 41% Buy 41%
Related companies
Delphi Automotive ...   (13)
Hold 23% Buy 77%
Autoliv, Inc.   (14)
Sell 29% Hold 64% Buy
Trw Automotive ...   (12)
Hold 50% Buy 50%
Lkq Corporation   (14)
Hold 50% Buy 50%
Magna ...   (19)
Sell Hold 42% Buy 47%
Johnson Controls, ...   (33)
Sell Hold 36% Buy 61%
Show  

Date (ET)MemberRatingYTD
Gains
 
1/21/2008  
Buy
  
2/20/2008  
Buy
  
4/18/2008  
Hold
  
1/26/2009  
Sell
  
2/25/2009  
Buy
  
4/3/2009  
Sell
  
2/14/2011  
Sell
  
7/18/2011  
Buy
  
10/16/2012  
Hold
  
11/27/2012  
Buy
  
6/12/2013  
Hold
  
7/17/2013  
Hold
  
10/15/2013  
Hold
  
2/19/2014  
Hold
  
6/18/2015  
Buy
  
10/15/2015  
Hold
  
10/20/2015  
Buy
  

* As of 8/27/2015 12:00 AM
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy